Showing results (1271-1280 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|April 2, 2015
Anti-programmed cell death-1 therapy and insulin-dependent diabetes: a case reportJuan Martin-Liberal, Andrew Js Furness, Kroopa Joshi, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Cancer patients' lymphocytes contain CD3+ CD4+ cells that proliferate in response to autologous tumor cells in the presence of exogenous low-dose interleukin-2 and autologous accessory cellsM Radrizzani, M Quaia, B Benedetti, et al.Cancer Immunology, Immunotherapy : CII|June 20, 2014
Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in miceSungjune Kim, Rupal Ramakrishnan, Sergio Lavilla-Alonso, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Combined effects of interferon alpha and interleukin 2 on the induction of a vascular leak syndrome in miceR K Puri, S A RosenbergCancer Immunology, Immunotherapy : CII|April 13, 2015
Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functionsYannick Willemen, Johan M J Van den Bergh, Eva Lion, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2015
FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinomaSimone Punt, Marjolein E van Vliet, Vivian M Spaans, et al.Cancer Immunology, Immunotherapy : CII|March 22, 2015
Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinomaLaura K Aguilar, Lawrence A Shirley, Vincent M Chung, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Effective drug-antibody targeting using a novel monoclonal antibody against the proliferative compartment of mammalian squamous carcinomasL Ding, J Samuel, G D MacLean, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Susceptibility of autologous target cells to lysis by lymphokine-activated effectors from interferon-alpha-treated chronic myelogenous leukaemia patientsG Pawelec, G Ehninger, H Schmidt, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1990
Postoperative active specific immunization in curatively resected colorectal cancer patients with a virus-modified autologous tumor cell vaccineB Lehner, P Schlag, W Liebrich, et al.Pageof 651